2024-01-30 08:39:01 ET
- Iterum Therapeutics ( ITRM ) +61% Announces Positive Topline Results from its Phase 3 REASSURE Clinical Trial of Oral Sulopenem in Uncomplicated Urinary Tract Infections.
- Kura Oncology ( KURA ) +16% Reports Positive Preliminary Ziftomenib Combination Data in Acute Myeloid Leukemia.
- Petros Pharmaceuticals ( PTPI ) +13% .
- Super Micro Computer ( SMCI ) +13% Q2 earnings call release
- 2seventy ( TSVT ) +13% rises as Regeneron acquires R&D assets.
- General Motors Company ( GM ) +8% rallies after profit guidance tops expectations; Detroit peers gain.
- Corbus Pharmaceuticals ( CRBP ) +8% reverses gains on common stock offering.
- Celestica ( CLS ) +7% .
- Compugen ( CGEN ) +7% .
- Arcus Biosciences ( RCUS ) +7% .
- Minim ( MINM ) +7% .
- Can-Fite Biopharma ( CANF ) +6% Expands the Out-Licensing Deal with Ewopharma to Include the Pancreatic Cancer Indication.
Read the full article on Seeking Alpha
For further details see:
CLS, CGEN and RCUS are among pre market gainers